Pivotal Financial Consulting

C-Level Executive with 25+ year track record of value creation.  Key highlights include:

​

Clinipace, CEO and Board Member

• Completed merger with dMed, creating the industry's first China based mid-size global CRO

• Executed growth plan resulting in significant backlog, sales, revenue and EBITDA expansion

• Navigated Covid pandemic business challenges

​

Theorem Clinical Research, CFO

• Led sale to Chiltern International resulting in a 20x+ return for private equity investors

• Developed strategic plan resulting in sales and revenue doubling and transforming an EBITDA loss to significant profitability

​

New England Research Institute (NERI) & Fairmount Partners, Consultant

• Assisted NERI founders and Fairmount Capital with a successful sale to HealthCore 

​

Metalmark Capital, Advisor

• Advised Metalmark with their acquisition of Premier Research

​

Court Square Capital, Advisor

• Advised Court Square with their acquisition of Celerion

​

Genstar Capital, Advisor

• Advised Genstar with their acquisition of Bracket Global

​

Drug Information Association (DIA)

• Board Observer

​

Power (a patient friendly platform for clinical trials)

• Adviser